Tech Company Financing Transactions

Meritage Pharma Funding Round

Meritage Pharma closed a $2 million financing round on 1/28/2011. Backers included private investors.

Transaction Overview

Company Name
Announced On
1/28/2011
Transaction Type
Venture Equity
Amount
$2,000,001
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12555 High Bluff Drive 385
San Diego, CA 92130
USA
Email Address
Overview
Meritage Pharma is committed to the development of prescription products based on proven safe and effective molecules to meet the unmet needs of patients and their caregivers. Meritage Pharma's initial product candidate is intended for the treatment of allergic inflammation of the gastrointestinal tract.
Profile
Meritage Pharma LinkedIn Company Profile
Social Media
Meritage Pharma Company Twitter Account
Company News
Meritage Pharma News
Facebook
Meritage Pharma on Facebook
YouTube
Meritage Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elaine Phillips
  Elaine Phillips LinkedIn Profile  Elaine Phillips Twitter Account  Elaine Phillips News  Elaine Phillips on Facebook
Chief Scientific Officer
Malcolm Hill
  Malcolm Hill LinkedIn Profile  Malcolm Hill Twitter Account  Malcolm Hill News  Malcolm Hill on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/28/2011: UsingMiles venture capital transaction
Next: 1/28/2011: HelioVolt venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary